Kidney Transplant Market- Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028

 

Kidney Transplant

A kidney transplant is dependent on a variety of conditions and circumstances, such as renal failure brought on by many causes (kidney trauma, severe dehydration). It is not a common practise in many nations because a human can survive for years on just one kidney. Unaffordability is another factor that prevents people in developing nations from receiving a Kidney Transplant. One of the key elements influencing the number of kidney transplant procedures is the availability of a donor.

The global Kidney Transplant Market is estimated to be valued at US$ 81,037 Mn in 2021 and is expected to register a CAGR of 3.1% and reach US$ 1,06,179 Mn by 2028.

The most recent epidemic was the coronavirus (COVID-19) pandemic, which was first identified on December 31, 2019, in Wuhan, China. Global supply, distribution, and manufacturing of medical goods were all hampered by the shutdown. Additionally, the number of people visiting hospitals and clinics has decreased by more than 70% as a result of social isolation during this pandemic. This has reduced the number of operations, clinical trials, research and development projects, and other activities, which has hurt the market's expansion.

Segments covered:

By Type: Living Donor Transplant, Paired Kidney Transplant, Deceased Donor Transplant

By Age: Children, Adults

By End Users: Hospitals & Clinics, Transplant Centers

The COVID-19 epidemic has, however, increased the demand for PPE kits and gloves, which has resulted in a rise in PPE kit production, supporting the Kidney Transplant Market growth. When kidney transplantation rates drop, so do organ procurement rates. The U.K. recorded a 39% decline in organ referrals in 2020 compared to the previous year, and France reported a 16% decrease in total deceased organ referrals. These declines were caused in part by the procurement difficulties transplant programmes and organisations faced, such as limited testing capacity and delayed COVID-19 test results, limited operating room availability, and rules requiring the avoidance of unnecessary clinical activities to protect personnel and protective equipment.

Major Vendors involved are Sanofi, Pfizer, Inc., Novartis AG., B. Braun Melsungen AG, Fresenius Medical Care, Medtronic, Preservation Solution Inc., TransMedics, Inc., Organ Recovery Systems, and Transonic Systems Inc.

Comments

Popular posts from this blog

Security Robot Market is Estimated To Witness High Growth Owing To Increasing Demand for Enhanced Surveillance

The Ever-Evolving Landscape of the Scottish Whisky Market during the Forecast Period 2019-2027

Monochloroacetic Acid (MCAA) Market Is Estimated To Witness High Growth Owing To Increasing Demand for Surfactants and Herbicides